TEST BANK lc
Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 6th Edition
lc lc lc lc lc lc lc
Author: Teri Moser Woo and Wendy L. Wright
lc lc lc lc lc lc lc
, TABLE OF CONTENT lc lc
Chapter 1. The Role of the Advanced Practice Nurse as Prescriber ........................................................................ 4
lc lc lc lc lc lc lc lc lc lc
Chapter 2. Review of Basic Principles of Pharmacology........................................................................................ 5
lc lc lc lc lc lc lc
Chapter 3. Rational Drug Selection ...................................................................................................................... 11
lc lc lc lc
Chapter 4. Legal and Professional Issues in Prescribing ....................................................................................... 14
lc lc lc lc lc lc lc
Chapter 5. Adverse Drug Reactions ..................................................................................................................... 16
lc lc lc lc
Chapter 6. An Introduction to Pharmacogenomics ............................................................................................... 19
lc lc lc lc lc
Chapter 7. Nutrition and Nutraceuticals ............................................................................................................... 22
lc lc lc lc
Chapter 8. Herbal Therapies ................................................................................................................................ 28
lc lc lc
Chapter 9. Cannabis ............................................................................................................................................. 31
lc lc
Chapter 10. Pharmacoeconomics ......................................................................................................................... 35
lc lc
Chapter 11. Drugs Affecting the Autonomic Nervous System ............................................................................. 38
lc lc lc lc lc lc lc
Chapter 12. Drugs Affecting the Central Nervous System ................................................................................... 45
lc lc lc lc lc lc lc
Chapter 13. Drugs Affecting the Cardiovascular and Renal Systems ................................................................... 53
lc lc lc lc lc lc lc lc
Chapter 14. Drugs Affecting the Respiratory System........................................................................................... 61
lc lc lc lc lc lc
Chapter 15. Drugs Affecting the Hematological System ...................................................................................... 65
lc lc lc lc lc lc
Chapter 16. Drugs Affecting the Immune System: Vaccines and Immunoglobulins ............................................ 69
lc lc lc lc lc lc lc lc lc
Chapter 17. Drugs Affecting the Immune System: Immunomodulators ............................................................... 75
lc lc lc lc lc lc lc
Chapter 18. Drugs Affecting the Gastrointestinal System .................................................................................... 77
lc lc lc lc lc lc
Chapter 19. Drugs Affecting the Endocrine System: Pancreatic Hormones and Antidiabetic Drugs ...................... 80
lc lc lc lc lc lc lc lc lc lc lc
Chapter 20. Drugs Affecting the Endocrine System: Pituitary, Thyroid, and Adrenal Drugs ............................... 83
lc lc lc lc lc lc lc lc lc lc lc
Chapter 21. Drugs Affecting the Reproductive System ........................................................................................ 86
lc lc lc lc lc lc
Chapter 22. Drugs Affecting the Bones and Joints ............................................................................................... 92
lc lc lc lc lc lc lc
Chapter 23. Drugs Affecting the Integumentary System ...................................................................................... 96
lc lc lc lc lc lc
Chapter 24. Drugs Used to Treat Bacterial Infections ........................................................................................ 101
lc lc lc lc lc lc lc
Chapter 25. Drugs Used to Treat Viral, Fungal, and Protozoal Infections .......................................................... 105
lc lc lc lc lc lc lc lc lc lc
Chapter 26. Drugs Used to Treat Inflammatory Processes ................................................................................. 108
lc lc lc lc lc lc lc
Chapter 27. Drugs Used to Treat Eye and Ear Disorders .................................................................................... 111
lc lc lc lc lc lc lc lc lc
Chapter 28. Anemia ........................................................................................................................................... 113
lc lc
Chapter 29. Anxiety and Depression .................................................................................................................. 116
lc lc lc lc
Chapter 30. Attention Deficit-Hyperactivity Disorder ....................................................................................... 120
lc lc lc lc
Chapter 31. Asthma and Allergy ........................................................................................................................ 122
lc lc lc lc
Chapter 32. Chronic Obstructive Pulmonary Disease ........................................................................................ 125
lc lc lc lc lc
Chapter 33. Contraception ................................................................................................................................. 127
lc lc
Chapter 34. COVID-19: Acute and Chronic ...................................................................................................... 130
lc lc lc lc lc
Chapter 35. Dermatological Conditions ............................................................................................................. 134
lc lc lc
Chapter 36. Diabetes Management .................................................................................................................... 138
lc lc lc
Chapter 37. Gastroesophageal Reflux and Peptic Ulcer Disease ........................................................................ 146
lc lc lc lc lc lc lc
Chapter 38. Headaches ...................................................................................................................................... 149
lc lc
Chapter 39. Heart Failure ................................................................................................................................... 153
lc lc lc
Chapter 40. HIV Disease and Acquired Immunodeficiency Syndrome .............................................................. 158
lc lc lc lc lc lc lc
Chapter 41. Menopausal Hormone Therapy ...................................................................................................... 161
lc lc lc lc
,Chapter 42. Hyperlipidemia ............................................................................................................................... 164
lc lc
Chapter 43. Hypertension .................................................................................................................................. 169
lc lc
Chapter 44. Hyperthyroidism and Hypothyroidism ........................................................................................... 174
lc lc lc lc
Chapter 45. Obesity ........................................................................................................................................... 177
lc lc
Chapter 46. Pain Management: Acute and Chronic Pain .................................................................................... 181
lc lc lc lc lc lc lc
Chapter 47. Pneumonia ...................................................................................................................................... 185
lc lc
Chapter 48. Sexually Transmitted Diseases and Vaginitis ................................................................................. 187
lc lc lc lc lc lc
Chapter 49. Substance Use Disorders ................................................................................................................ 190
lc lc lc lc
Chapter 50. Tuberculosis ................................................................................................................................... 195
lc lc
Chapter 51. Upper Respiratory Tract Infection, Pharyngitis, Sinusitis, Otitis Media, and Otitis Externa ............. 197
lc lc lc lc lc lc lc lc lc lc lc lc
Chapter 52. Urinary Tract Infections.................................................................................................................. 200
lc lc lc lc
Chapter 53. Women as Patients .......................................................................................................................... 203
lc lc lc lc
Chapter 54. Men as Patients ............................................................................................................................... 207
lc lc lc lc
Chapter 55. Pediatric Patients ............................................................................................................................ 209
lc lc lc
Chapter 57. Geriatric Patients ............................................................................................................................ 213
lc lc lc
, Woo 1
Pharmacotherapeutics for APN Prescribers, 6e Ch01
Chapter 1. The Role of the Advanced Practice Nurse as Prescriber
lc lc lc lc lc lc lc lc lc lc
MULTIPLE CHOICE lc
1. Nurse practitioner prescriptive authority is regulated by:
lc lc lc lc lc lc
A. The National Council of State Boards of Nursing
lc lc lc lc lc lc lc
B. The U.S. Drug Enforcement Administration
lc lc lc lc
C. The State Board of Nursing for each state
lc lc lc lc lc lc lc
D. The State Board of Pharmacy
lc lc lc lc
ANS: C l c PTS: l c l c 1
2. The benefits to the patient of having an advanced practice registered nurse (APRN) prescriber inc
lc lc lc lc lc lc lc lc lc lc lc lc lc lc
lude:
A. Nurses know more about pharmacology than other prescribers because they take it bo
lc lc lc lc lc lc lc lc lc lc lc lc
th in their basic nursing program and in their APRN program.
lc lc lc lc lc lc lc lc lc lc
B. Nurses care for the patient from a holistic approach and include the patient in de
lc lc lc lc lc lc lc lc lc lc lc lc lc lc
cision-making regarding their care. lc lc lc
C. APRNs are less likely to prescribe narcotics and other controlled substances.
lc lc lc lc lc lc lc lc lc lc
D. APRNs are able to prescribe independently in all states, whereas a physician’s as
lc lc lc lc lc lc lc lc lc lc lc lc
sistant needs to have a physician supervising their practice.
lc lc lc lc lc lc lc lc
ANS: B l c PTS: l c l c 1
3. Clinical judgment in prescribing includes:
lc lc lc lc
A. Factoring in the cost to the patient of the medication prescribed
lc lc lc lc lc lc lc lc lc lc
B. Always prescribing the newest medication available for the disease process
lc lc lc lc lc lc lc lc lc
C. Handing out drug samples to poor patients lc lc lc lc lc lc
D. Prescribing all generic medications to cut costs lc lc lc lc lc lc
ANS: A l c PTS: l c l c 1
4. The process for choosing an effective drug for a disorder includes:
lc lc lc lc lc lc lc lc lc lc
A. Asking the patient what drug they think would work best for them
lc lc lc lc lc lc lc lc lc lc lc
B. Consulting nationally recognized guidelines for disease management lc lc lc lc lc lc
C. Prescribing medications that are available as samples before writing a prescription
lc lc lc lc lc lc lc lc lc lc
D. Following U.S. Drug Enforcement Administration guidelines for prescribing
lc lc lc lc lc lc lc
ANS: B l c PTS: l c l c 1
5. Nonintentional nonadherence of drug therapy may occur due to: lc lc lc lc lc lc lc lc
A. Belief that medication does not worklc lc lc lc lc
B. Adverse drug reactions lc lc
C. Chronic conditions that require daily therapy lc lc lc lc lc
D. Forgetfulness or distraction lc lc
ANS: D l c PTS: l c l c 1
Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 6th Edition
lc lc lc lc lc lc lc
Author: Teri Moser Woo and Wendy L. Wright
lc lc lc lc lc lc lc
, TABLE OF CONTENT lc lc
Chapter 1. The Role of the Advanced Practice Nurse as Prescriber ........................................................................ 4
lc lc lc lc lc lc lc lc lc lc
Chapter 2. Review of Basic Principles of Pharmacology........................................................................................ 5
lc lc lc lc lc lc lc
Chapter 3. Rational Drug Selection ...................................................................................................................... 11
lc lc lc lc
Chapter 4. Legal and Professional Issues in Prescribing ....................................................................................... 14
lc lc lc lc lc lc lc
Chapter 5. Adverse Drug Reactions ..................................................................................................................... 16
lc lc lc lc
Chapter 6. An Introduction to Pharmacogenomics ............................................................................................... 19
lc lc lc lc lc
Chapter 7. Nutrition and Nutraceuticals ............................................................................................................... 22
lc lc lc lc
Chapter 8. Herbal Therapies ................................................................................................................................ 28
lc lc lc
Chapter 9. Cannabis ............................................................................................................................................. 31
lc lc
Chapter 10. Pharmacoeconomics ......................................................................................................................... 35
lc lc
Chapter 11. Drugs Affecting the Autonomic Nervous System ............................................................................. 38
lc lc lc lc lc lc lc
Chapter 12. Drugs Affecting the Central Nervous System ................................................................................... 45
lc lc lc lc lc lc lc
Chapter 13. Drugs Affecting the Cardiovascular and Renal Systems ................................................................... 53
lc lc lc lc lc lc lc lc
Chapter 14. Drugs Affecting the Respiratory System........................................................................................... 61
lc lc lc lc lc lc
Chapter 15. Drugs Affecting the Hematological System ...................................................................................... 65
lc lc lc lc lc lc
Chapter 16. Drugs Affecting the Immune System: Vaccines and Immunoglobulins ............................................ 69
lc lc lc lc lc lc lc lc lc
Chapter 17. Drugs Affecting the Immune System: Immunomodulators ............................................................... 75
lc lc lc lc lc lc lc
Chapter 18. Drugs Affecting the Gastrointestinal System .................................................................................... 77
lc lc lc lc lc lc
Chapter 19. Drugs Affecting the Endocrine System: Pancreatic Hormones and Antidiabetic Drugs ...................... 80
lc lc lc lc lc lc lc lc lc lc lc
Chapter 20. Drugs Affecting the Endocrine System: Pituitary, Thyroid, and Adrenal Drugs ............................... 83
lc lc lc lc lc lc lc lc lc lc lc
Chapter 21. Drugs Affecting the Reproductive System ........................................................................................ 86
lc lc lc lc lc lc
Chapter 22. Drugs Affecting the Bones and Joints ............................................................................................... 92
lc lc lc lc lc lc lc
Chapter 23. Drugs Affecting the Integumentary System ...................................................................................... 96
lc lc lc lc lc lc
Chapter 24. Drugs Used to Treat Bacterial Infections ........................................................................................ 101
lc lc lc lc lc lc lc
Chapter 25. Drugs Used to Treat Viral, Fungal, and Protozoal Infections .......................................................... 105
lc lc lc lc lc lc lc lc lc lc
Chapter 26. Drugs Used to Treat Inflammatory Processes ................................................................................. 108
lc lc lc lc lc lc lc
Chapter 27. Drugs Used to Treat Eye and Ear Disorders .................................................................................... 111
lc lc lc lc lc lc lc lc lc
Chapter 28. Anemia ........................................................................................................................................... 113
lc lc
Chapter 29. Anxiety and Depression .................................................................................................................. 116
lc lc lc lc
Chapter 30. Attention Deficit-Hyperactivity Disorder ....................................................................................... 120
lc lc lc lc
Chapter 31. Asthma and Allergy ........................................................................................................................ 122
lc lc lc lc
Chapter 32. Chronic Obstructive Pulmonary Disease ........................................................................................ 125
lc lc lc lc lc
Chapter 33. Contraception ................................................................................................................................. 127
lc lc
Chapter 34. COVID-19: Acute and Chronic ...................................................................................................... 130
lc lc lc lc lc
Chapter 35. Dermatological Conditions ............................................................................................................. 134
lc lc lc
Chapter 36. Diabetes Management .................................................................................................................... 138
lc lc lc
Chapter 37. Gastroesophageal Reflux and Peptic Ulcer Disease ........................................................................ 146
lc lc lc lc lc lc lc
Chapter 38. Headaches ...................................................................................................................................... 149
lc lc
Chapter 39. Heart Failure ................................................................................................................................... 153
lc lc lc
Chapter 40. HIV Disease and Acquired Immunodeficiency Syndrome .............................................................. 158
lc lc lc lc lc lc lc
Chapter 41. Menopausal Hormone Therapy ...................................................................................................... 161
lc lc lc lc
,Chapter 42. Hyperlipidemia ............................................................................................................................... 164
lc lc
Chapter 43. Hypertension .................................................................................................................................. 169
lc lc
Chapter 44. Hyperthyroidism and Hypothyroidism ........................................................................................... 174
lc lc lc lc
Chapter 45. Obesity ........................................................................................................................................... 177
lc lc
Chapter 46. Pain Management: Acute and Chronic Pain .................................................................................... 181
lc lc lc lc lc lc lc
Chapter 47. Pneumonia ...................................................................................................................................... 185
lc lc
Chapter 48. Sexually Transmitted Diseases and Vaginitis ................................................................................. 187
lc lc lc lc lc lc
Chapter 49. Substance Use Disorders ................................................................................................................ 190
lc lc lc lc
Chapter 50. Tuberculosis ................................................................................................................................... 195
lc lc
Chapter 51. Upper Respiratory Tract Infection, Pharyngitis, Sinusitis, Otitis Media, and Otitis Externa ............. 197
lc lc lc lc lc lc lc lc lc lc lc lc
Chapter 52. Urinary Tract Infections.................................................................................................................. 200
lc lc lc lc
Chapter 53. Women as Patients .......................................................................................................................... 203
lc lc lc lc
Chapter 54. Men as Patients ............................................................................................................................... 207
lc lc lc lc
Chapter 55. Pediatric Patients ............................................................................................................................ 209
lc lc lc
Chapter 57. Geriatric Patients ............................................................................................................................ 213
lc lc lc
, Woo 1
Pharmacotherapeutics for APN Prescribers, 6e Ch01
Chapter 1. The Role of the Advanced Practice Nurse as Prescriber
lc lc lc lc lc lc lc lc lc lc
MULTIPLE CHOICE lc
1. Nurse practitioner prescriptive authority is regulated by:
lc lc lc lc lc lc
A. The National Council of State Boards of Nursing
lc lc lc lc lc lc lc
B. The U.S. Drug Enforcement Administration
lc lc lc lc
C. The State Board of Nursing for each state
lc lc lc lc lc lc lc
D. The State Board of Pharmacy
lc lc lc lc
ANS: C l c PTS: l c l c 1
2. The benefits to the patient of having an advanced practice registered nurse (APRN) prescriber inc
lc lc lc lc lc lc lc lc lc lc lc lc lc lc
lude:
A. Nurses know more about pharmacology than other prescribers because they take it bo
lc lc lc lc lc lc lc lc lc lc lc lc
th in their basic nursing program and in their APRN program.
lc lc lc lc lc lc lc lc lc lc
B. Nurses care for the patient from a holistic approach and include the patient in de
lc lc lc lc lc lc lc lc lc lc lc lc lc lc
cision-making regarding their care. lc lc lc
C. APRNs are less likely to prescribe narcotics and other controlled substances.
lc lc lc lc lc lc lc lc lc lc
D. APRNs are able to prescribe independently in all states, whereas a physician’s as
lc lc lc lc lc lc lc lc lc lc lc lc
sistant needs to have a physician supervising their practice.
lc lc lc lc lc lc lc lc
ANS: B l c PTS: l c l c 1
3. Clinical judgment in prescribing includes:
lc lc lc lc
A. Factoring in the cost to the patient of the medication prescribed
lc lc lc lc lc lc lc lc lc lc
B. Always prescribing the newest medication available for the disease process
lc lc lc lc lc lc lc lc lc
C. Handing out drug samples to poor patients lc lc lc lc lc lc
D. Prescribing all generic medications to cut costs lc lc lc lc lc lc
ANS: A l c PTS: l c l c 1
4. The process for choosing an effective drug for a disorder includes:
lc lc lc lc lc lc lc lc lc lc
A. Asking the patient what drug they think would work best for them
lc lc lc lc lc lc lc lc lc lc lc
B. Consulting nationally recognized guidelines for disease management lc lc lc lc lc lc
C. Prescribing medications that are available as samples before writing a prescription
lc lc lc lc lc lc lc lc lc lc
D. Following U.S. Drug Enforcement Administration guidelines for prescribing
lc lc lc lc lc lc lc
ANS: B l c PTS: l c l c 1
5. Nonintentional nonadherence of drug therapy may occur due to: lc lc lc lc lc lc lc lc
A. Belief that medication does not worklc lc lc lc lc
B. Adverse drug reactions lc lc
C. Chronic conditions that require daily therapy lc lc lc lc lc
D. Forgetfulness or distraction lc lc
ANS: D l c PTS: l c l c 1
